| Judul | Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer / Christian Klein |
| Pengarang | Christian Klein Sophia Karagiannis Ann White |
| Penerbitan | 4052 Basel, Switzerland : MDPI, 2026 |
| Deskripsi Fisik | 186 |
| ISBN | 978-3-7258-6771-4 |
| Subjek | Biology & Life Sciences, |
| Catatan | "Summary In the past decade, cancer immunotherapy has revolutionized the treatment of hematological and solid tumors, resulting in the approval of checkpoint inhibitory antibodies, CAR-T cell therapies, and T cells engaging bispecific antibodies. Despite this progress, the lack of response and/or relapse and subsequent resistance to immunotherapy remain major clinical challenges requiring the development of optimized therapeutic agents and novel principles for targeting cancer. For this purpose, the application of state-of-the-art antibody engineering continues to play a key role. This Special Issue covers recent progress and novel concepts in the engineering of antibody-based immunotherapies, including monoclonal antibodies, antibody engineering, bi- and multispecific antibodies, photo-and radioimmunotherapy and CAR-T cell therapy manufacturing." |
| Bentuk Karya | Tidak ada kode yang sesuai |
| Target Pembaca | Tidak ada kode yang sesuai |
| Lokasi Akses Online |
https://www.mdpi.com/books/reprint/12454-emerging-antibody-engineering-strategies-and-applications-for-immunotherapy-of-cancer |
| No Barcode | No. Panggil | Akses | Lokasi | Ketersediaan |
|---|---|---|---|---|
| 114026192 | 616.994 061 Chr e | Baca Online | Perpustakaan Pusat - Online Resources Ebook |
Tersedia |
| Tag | Ind1 | Ind2 | Isi |
| 001 | INLIS000000000168190 | ||
| 005 | 20260415030934 | ||
| 007 | ta | ||
| 008 | 260415################|##########|#|## | ||
| 020 | # | # | $a 978-3-7258-6771-4 |
| 035 | # | # | $a 0010-0426000339 |
| 082 | # | # | $a 616.994 061 |
| 084 | # | # | $a 616.994 061 Chr e |
| 100 | 0 | # | $a Christian Klein |
| 245 | 1 | # | $a Emerging Antibody Engineering Strategies and Applications for Immunotherapy of Cancer /$c Christian Klein |
| 260 | # | # | $a 4052 Basel, Switzerland :$b MDPI,$c 2026 |
| 300 | # | # | $a 186 |
| 505 | # | # | $a "Summary In the past decade, cancer immunotherapy has revolutionized the treatment of hematological and solid tumors, resulting in the approval of checkpoint inhibitory antibodies, CAR-T cell therapies, and T cells engaging bispecific antibodies. Despite this progress, the lack of response and/or relapse and subsequent resistance to immunotherapy remain major clinical challenges requiring the development of optimized therapeutic agents and novel principles for targeting cancer. For this purpose, the application of state-of-the-art antibody engineering continues to play a key role. This Special Issue covers recent progress and novel concepts in the engineering of antibody-based immunotherapies, including monoclonal antibodies, antibody engineering, bi- and multispecific antibodies, photo-and radioimmunotherapy and CAR-T cell therapy manufacturing." |
| 650 | # | # | $a Biology & Life Sciences, |
| 700 | 0 | # | $a Ann White |
| 700 | 0 | # | $a Sophia Karagiannis |
| 856 | # | # | $a https://www.mdpi.com/books/reprint/12454-emerging-antibody-engineering-strategies-and-applications-for-immunotherapy-of-cancer |
| 990 | # | # | $a 114026192 |
Content Unduh katalog
Karya Terkait :